Gyre Therapeutics (GYRE) Exchange Rate Effect (2023 - 2026)
Gyre Therapeutics (GYRE) reported Exchange Rate Effect of $285000.0 for Q1 2026, up 470.0% year-over-year from $50000.0 in Q1 2025, and up 124.41% quarter-over-quarter from $127000.0 in Q4 2025.
Gyre Therapeutics (GYRE) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has 4 years of Exchange Rate Effect data on file, last reported at $285000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $285000.0, up 470.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $578000.0 (up 426.55% YoY), and the FY2025 annual result was $343000.0, up 225.64% from the prior year.
- Exchange Rate Effect improved to $285000.0 in Q1 2026 per GYRE's latest filing, from $127000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $285000.0 in Q1 2026 and troughed at -$900000.0 in Q2 2023.
- A 4-year average of $4384.6 and a median of $106000.0 in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2024 and 2026: Exchange Rate Effect plunged 210.39% in 2024, then soared 470.0% in 2026.
- A 4-year view of Exchange Rate Effect shows it stood at $231000.0 in 2023, then sank by 210.39% to -$255000.0 in 2024, then soared by 149.8% to $127000.0 in 2025, then soared by 124.41% to $285000.0 in 2026.
- Business Quant data shows GYRE's Exchange Rate Effect at $285000.0 in Q1 2026, $127000.0 in Q4 2025, and $117000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn | 285,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 285,000.00 |
| Mar 31, 2026 | 285,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 117,000.00 |
| Sep 30, 2025 | 117,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | -255,000.00 |
| Dec 31, 2024 | -255,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Jun 30, 2024 | -78,000.00 |
| Jun 30, 2024 | -78,000.00 |
| Mar 31, 2024 | -46,000.00 |
| Mar 31, 2024 | -46,000.00 |
| Dec 31, 2023 | 231,000.00 |
| Dec 31, 2023 | 231,000.00 |